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Abstract
Background: Chronic diseases are illnesses or health conditions that 
are persistent and have long-term effects on the physical status of the 
human body. The manifestation of a chronic disease is the result of 
coexistence of multiple chronic diseases. Especially, the chronic kidney 
disease (CKD) is a representative chronic syndrome of multifactorial 
affair, characterized by a gradual progression.
Methods: This study considered 81 patients with CKD and investi-
gated the correlation between the disease and the patients' demo-
graphics, anamnesis, and clinical presentation, as well as the potential 
relationship between the disease and other illnesses.
Results: A significant number of diseases can lead to the manifes-
tation of CKD, and notably, many of them are idiopathic. However, 
despite the rapid development in medical science and pharmaceutical 
technology and a plethora of research trials, there is a lack of ability 
to identify and analyze the causes and pathophysiologic mechanisms 
that are responsible for the manifestation of CKD.
Conclusions: This retrospective study investigates the factors that 
may play a role in the manifestation of CKD through the knowledge 
and research of both conventional medicine and homeopathy.
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Background
The causes of chronic diseases seemingly have unsatisfactory expla-
nations for modern medicine. Thus, medical science defines a set 
of illnesses as diseases of unknown etiology (idiopathic diseases), 
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in which the disease's cause is not readily appa-
rent. Examples include idiopathic hypertension, 
idiopathic glomerulonephritis, fever of unknown 
origin, urticaria of unknown origin, pulmonary 
fibrosis, and, by extension, chronic autoimmune 
diseases, malignancies, and focal segmental glo-
merulosclerosis [1-2]. In addition, the "comprehen-
sive" causative relationships between the cause 
and the progression of a disease do not seem to 
explain this complexity [3]. 
Chronic diseases are illnesses or other health 
conditions that are persistent and have long-term 
effects on the physical status of the human body. 
They disrupt and undermine the patient's health to 
such a degree that the energy of the vital force that 
automatically drives life can defy these diseases only 
in part and without effect both at their onset and 
during their progression [4]. The manifestation of a 
chronic disease is a multifactorial affair, especially in 
chronic kidney disease (CKD) which is a priori the 
result of the coexistence of multiple chronic disea-
ses. This also constitutes a first approach, according 
to conventional medicine, as to why not all humans 
with the same diseases also present the same pro-
gression or complications [5]. CKD is a representa-
tive chronic syndrome, since it is characterized by a 
gradual progression and multifactorial nature [6-7]. 
Significant number of diseases can lead to the 
manifestation of CKD, and, notably, many of them 
are idiopathic. As evidenced by literature and daily 
clinical practice, there is an inability to identify and 
analyze the causes and pathophysiologic mecha-
nisms that are responsible for the manifestation 
of CKD. This is despite the rapid development in 
medical science and pharmaceutical technology as 
well as a plethora of research trials. This study the-
refore investigates factors that may play a role in 
the manifestation of CKD through the knowledge 
and research of both conventional medicine and 
homeopathy. 
Homeopathy approaches the human body holis-
tically, considering it as a whole–a set of interacting 
mental, emotional, and physiological processes. 
The fundamental principle of homeopathy is that 
each symptom the body develops is the expression 
of its defense and its effort to combat the disorder 
[8]. According to Professor Vithoulkas, the key di-
fferences between conventional medicine and ho-
meopathy lie in the principles encompassing them. 
Specifically, conventional medicine looks for the 
causes of a disease and targets it directly (e.g., a 
bacterium or a virus), whereas homeopathy tries to 
stimulate and strengthen the defense mechanism 
so that the body can address the underlying cause 
through its immune system. When adverse factors 
are more potent than the body's defenses, symp-
toms manifest and constitute the expression of the 
disorder on a physical and/or mental level [9-10]. 
A miasm is the body's predisposition for certain 
categories of diseases and something that hinders 
the action of the homeopathic remedy. As a result, 
the body's vital force is unable to fight them. Ho-
meopathic medicine defines a miasm as a "peculiar 
morbid derangement of the vital force" of the hu-
man body [10-14]. According to Hahnemann, the 
initial exposure of the body to miasms causes local 
symptoms, such as skin or venereal diseases, but if 
these symptoms are suppressed by chemical me-
dications, the cause–the miasm–goes deeper and 
begins to manifest itself in the form of diseases of 
internal organs. Thus, homeopathy maintains that 
the attempt to treat diseases by directly addressing 
their symptoms (as usually applied in conventional 
medicine) is ineffective [15-18]. Notably, according 
to the homeopathic analysis of miasms, the pre-
disposed weakness of the human body's defense 
mechanism can be affected by three major factors: 
1) the hereditary effect, 2) potent infectious disea-
ses, and 3) previous therapies and vaccinations. In 
addition, for a deeper disorder, the internal miasm 
will manifest itself as a serious disease following 
exposure to stress, poor living conditions, and 
improper and exhaustive allopathic therapy [15]. 
Consequently, according to the law of disease sup-
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pression, when a disease is not treated in depth 
and causally, then it is simply suppressed. A disease 
manifesting in the body must be cured and, ac-
cording to the homeopathic view, by treating the 
symptoms only, one does not truly address the 
disease because one is applying a mere superficial 
treatment of deeper health disorders. Suppressing 
the symptoms of a disease often causes adverse 
effects on the body. The suppressed disease tends 
to affect deeper structures and settles in healthier 
tissues and organs [20-21]. The consolidated theory 
on disease constitutes a valuable source of infor-
mation and understanding of the natural history 
of a disease, since it also allows for the analysis of 
symptoms as well as the pathophysiological be-
havior of the human body. Thus, it is interesting 
that through the life of a person, from birth to 
death, there is a 'continuum' in the pathological 
conditions a person may experience. The body, as 
a whole, suffers deeply any time there is an acute 
or a chronic condition that is either maltreated or 
neglected. Chronic and acute diseases in the me-
dical history of a person constitute a rigidly related 
chain of immune responses in the form of a real 
'continuum' that at every point in time indicates 
the end result of this continuum, [4]. Suppression 
of symptoms and diseases, which is often achieved 
through excess chemical agents, often overwhelms 
the body's natural defenses and forces the immune 
system to compromise. This starts a deeper line of 
defense, which then constitutes the beginning of 
a new chronic condition [19].
Study Objective
The objectives of this study are: 1) to investigate the 
correlation between the disease and the patients' 
demographics, 2) to comparatively evaluate the re-
lationship between the disease and the existence of 
other infections, and 3) factors regarding the anam-
nesis and the clinical presentation of the patients.
Methods
This study included 81 patients with CKD and 
investigated the correlation between the disea-
se and the patients' demographics, anamnesis, 
and clinical presentation, as well as the poten-
tial relationship between the disease and other 
illnesses. Women accounted for 51.8% of study 
participants; the remaining 48.2% were men. The 
median age was 60.7 years with a standard devia-
tion of 11.39 years (range: 38 - 85 years). At the 
start of the study, we recorded the sex and the 
age of the participants, the age of onset of CKD, 
disease treatments, clinical presentation, and 
anamnesis. Specifically, clinical presentation in-
cluded whether the subject developed fever (and 
how high) or had had high fever in recent years, 
infections (and the age of onset and treatment), 
and relapses. Reporting anamnesis included fre-
quent use of antibiotics or chronic use of chemical 
medicines, as well as a family history of kidney 
disease or sexually transmitted diseases. 
Questionnaires were completed following in-
terview of the subjects. We studied and analyzed 
descriptors of the variables. Standard measures of 
position and dispersion were used for the descrip-
tion of demographics and the recording of the fre-
quency and the relative frequency of the questions 
included in the main questionnaire. For the poten-
tial correlation between personal details, as well as 
the various factors reported regarding the health 
status of patients with CKD, we used Pearson X2 
(chi-square) heterogeneity test. Where the condi-
tions were not met, we used Fisher’s exact test. In 
addition, Pearson's correlation coefficient was used 
to check the potential relationships between quan-
titative variables. Reported p-values were based on 
two-sided tests, and p < 0.05 was considered sta-
tistically significant. The software SPSS (SPSS Inc., 
2003, Chicago, USA) was used for the statistical 
analysis.
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Results
Basic Descriptive Data
With regards to the underlying cause of CKD, 
45.7% of subjects had chronic glomerulonephritis, 
23.2% tubular necrosis, 4.9% obstructive uropathy, 
and the remaining 26.2% had other diseases. For 
history of infection, 17.3% of the subjects had uri-
nary tract infection, and 76.5% developed some 
other type of infection. Only 6.2% did not develop 
any infection (Table 1). Next, we analyzed etiologi-
cal factors that were possibly connected to CKD. 
We found that 92.6% of subjects had concomitant 
physical illnesses, and 6.2% presented anxiety disor-
ders, while only one subject did not manifest other 
diseases (Table 2). Regarding chemical medicines, 
93.3% of subjects used antibiotics, while 66.7% 
frequently used them (Table 3). Moreover, 82.7% 
made chronic use of chemical medicines (Table 4). 
In addition, 43.1% of subjects developed infection 
relapse (Table 5). Notably, 23.5% of the subjects 
with CKD had a family history of kidney disease 
(Table 6) and 32.1% had a history of sexually trans-
mitted diseases (Table 7).
Statistically Significant Data 
There was a strong correlation (p-value < 0.001) 
between the disease and recurrent infections. We 
found that 79.17% of the aggregate sample pre-
sented recurrent infections. The correlation bet-
ween the disease and the development of recu-
rrent urinary tract infections was also statistically 
significant (Fisher’s exact p-value < 0.001) (Table 
8). In addition, we found a strong correlation (X2= 
79.98 and p-value < 0.001) between the disease 
and the chronic use of chemical medicines. We 
found that 95.7% of subjects with CKD were 
using chemical medicines (Table 9). Of the subjects 
asked about their history of sexually transmitted 
diseases, 26 of 81 patients with CKD reported 
a history of sexually transmitted diseases (STD). 
Of them, 53% reported urethritis (either gono-
coccal or non-gonococcal), 32% reported Human 
Papillomavirus (HPV) infection, and 15% could not 
report the type of the sexually transmitted disea-
se. Furthermore, there was a correlation between 
CKD and the history of STD (X2 = 19.33 and p-
value < 0.001). Finally, the relationship between 
the disease and the existence of causative factors 
(physical and mental stress) showed a strong co-
rrelation (X2 = 93.29 and a p-value < 0.001). Spe-
cifically, 92.6% of subjects with CKD presented 
physical stress, but only 6.2% presented mental 
stress (Table 10).
Table 1.  Distribution (absolute and relative frequen-
cies) of the health characteristics of patients 
enrolled in the study.
Disease N %
Chronic Glomerulonephritis 35 43,2
Chronic Tubular Necrosis 37 45,7
Obstructive Uropathy 4 4,9
Other 5 6,2
Total 81 100
Infection
None 5 6,2
Urinary Tract Infection 14 17,3
Other Infections 62 76,5
Total 81 100
Table 2.  Table of correlation between causative fac-
tors and CKD.
  Other Causative Factors - Possible 
Correlation with the Develompent 
of Chronic Renal Failure
N %
Physical Shock 75 92,6
Psychic Shock 5 6,2
None 1 1,2
Total 81 100
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Table 3.  Table of correlation between antibiotic use 
and CKD.
Treatment : Antibiotic/Other N %
No 5 6,7
Yes 70 93,3
Total 75 100
Frequent Use of Antibiotics
No 27 33,3
Yes 54 66,7
Total 81 100
Table 5.  Table of correlation between recurrent uri-
nary infection and CKD.
Chronic Use of Chemical Medicines N %
No 41 56,9
Yes 31 43,1
Total 72 100
Table 6.  Table of correlation between CKD and fa-
mily history.
Family History of Kidney Disease N %
No 62 76,5
Yes 19 23,5
Total 81 100
Table 7.  Table of correlation between CKD and 
sexually transmitted diseases.
History of Sexually Transmitted 
Diseases
N %
No 55 67,9
Yes 26 32,1
Table 8.  Table of correlation between the disease 
(Chronic Kidney Disease) and recurrent 
acute infections, for patients of the total 
sample.
Recurrent Acute 
Infections
n (%)
Total
Disease No Yes
CKD 5 (12,2) 76 (79,2) 81
X2= 53,4
p-value<0.001
Table 9.  Table of correlation between the disease 
(CKD) and the use of chemical drugs for 
patients of the total sample.
Use of Chemical Drugs 
n (%)
Total
Disease No Yes
CKD 14 (20,9) 67 (95,7) 81
X2= 79,98
p-value<0.001
Table 10.  Table of correlation between the disease 
and the availability of the causative fac-
tors, for patients of the total sample.
Causative Factors
n (%)
Total
Disease No
Psychic 
Shock
Physical 
Shock
CKD 1 (1,23) 5 (6,2) 75 (92,6)
81 (100)
Fisher’s 
exact
p-value
<0.001
Table 4.  Table of correlation between Chronic use 
of chemical medicines and CKD
Chronic Use of Chemical Medicines N %
No 14 17,3
Yes 67 82,7
Total 81 100
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Discussion
Chronic, non-communicable diseases are by far a 
major cause of mortality worldwide [5-7]. CKD is 
representative of such chronic conditions. It is cha-
racterized by its gradual progression and mainly by 
its numerous etiological factors. The progression of 
CKD does not consistently depend on the extent 
and the severity of the original cause/disease. Pa-
tients with CKD, even when the cause of kidney 
damage is not active, present with a deterioration 
of the renal function, and it is only in rare cases 
that they recover to a normal kidney function. The-
se observations indicate that it is not only the ori-
ginal cause that contributes to the progression of 
CKD but also various other factors, such as the diet, 
environmental conditions, physical status (defense 
mechanism), exposure to toxic agents, and age. A 
characteristic example in kidney failure is the struc-
tural and functional impairment of the nephrons, 
which are unable to maintain the body's homeos-
tasis [22-26]. The homeopathic approach considers 
that, in patients with CKD, miasms can potentially 
affect the body's structure. This way, in some CKD 
cases, the behavior of the "sick" system is predefi-
ned by its composition. End stage CKD is a chronic 
syndrome, resulting from one or more chronic di-
seases and leading to patients having to take long-
term medicines for the treatment of the underlying 
diseases. 
The effectiveness of homeopathy has been es-
tablished in numerous studies for a broad range 
of acute and chronic diseases [27]. A prospective 
study including 3,981 elderly subjects showed that 
the course of chronic diseases improved in a mar-
ked and sustained way in patients who received 
homeopathic treatment [28]. Its results strengthe-
ned the view that homeopathic treatment can play 
an important role in patients with chronic diseases. 
According to another meta-analysis, homeopathy 
is also effective in treating chronic allergies [29]. 
Of particular interest is a pooled study reviewing 
the 83 most important clinical trials conducted in 
the last thirty years regarding treatment of acute 
and chronic diseases. The authors prove that ho-
meopathy is a safe and effective treatment [30]. 
Furthermore, a comparative cohort study compa-
ring homeopathy and conventional medicine for 
treating acute respiratory tract and ear infections 
concluded that homeopathy is not inferior [31]. 
In addition, according to a nationwide study con-
ducted in Switzerland, patients receiving homeo-
pathic treatment in primary care were significantly 
satisfied compared to those receiving conventional 
medicine. The study also concluded that the risk 
of side effects in homeopathic treatment is two or 
three times lower than in conventional medicine 
[32]. Furthermore, a study conducted in Germany 
observed no medical toxicity or poisoning in chil-
dren inadvertently taking big quantities of homeo-
pathic remedies [33]. 
Not only do homeopathic treatments present a 
low risk of adverse reactions, the low cost of ho-
meopathic preparations is low and they distinction 
from the concept of placebo [29, 34]. In contrast, 
chronic use of chemical medicines can be interpre-
ted from a homeopathic view as a phenomenon 
of "symptom suppression," given that patients may 
develop terminal kidney failure [20]. In addition, it 
is well documented that a vast number of antimi-
crobial medicines administered for the treatment 
of urinary tract infections also cause nephrotoxici-
ty [35-61]. For example, the use of nitrofurantoin 
administered as a long term chemical prophylaxis 
in recurrent urinary tract infections led to acute 
granulomatous interstitial nephritis [52]. The use of 
antimicrobial medicines in patients with kidney di-
sorders, as well as their repeated use in recurrent 
infections, clearly constitutes an aggravating factor, 
leading to renal impairment. 
 Often, however, long-term administration of 
different chemical medicines is necessary for the 
treatment of CKD, despite adverse reactions. The 
epidemiology of renal impairment-inducing me-
dicines is complex, and the exact mechanism of 
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drug nephrotoxicity is unknown [51, 62]. The ad-
ministration of chemical preparations and vaccines 
seemingly causes a complex internal process with 
the participation of various organs, resulting in 
manifestation of toxicity. Chronic use of chemi-
cal substances/medicines can result in a status of 
health where not only there is no cure, but side 
effects and other pathologies may also be caused 
[35, 62-64]. This may also be the case for the re-
gular vaccination of patients with chronic diseases 
who develop chronic renal impairment. As pro-
ven in daily medical practice, a large number of 
patients do not know they are in early stages of 
renal impairment and take nephrotoxic antibiotics 
for forthcoming infections, thus further deterio-
rating their renal function. As earlier mentioned, 
homeopathic remedies are known to have fewer 
side effects and lower nephrotoxicity. More speci-
fically, in our study, 92.6% of subjects with CKD 
had other concomitant diseases, given that CKD 
is a chronic syndrome. Notably, 1% to 5% of pa-
tients receiving non-steroidal anti-inflammatory 
drugs develop nephrotoxic syndrome, and analge-
sic nephropathy is one of the chronic renal diseases 
leading to end stage CKD [65].
Thus, the concern arises whether analgesics and 
other chemical medicines have a substantial the-
rapeutic effect, as well as whether symptoms of 
chronic diseases are potentially suppressed as a 
result of their abuse. Many patients with CKD re-
ceive immunosuppressive therapy with corticoids 
making them susceptible to recurrent infections, 
which in turn are treated with antibiotics. Thus 
there is a vicious circle of the disease's manifesta-
tion and treatment. Since the nephrotoxicity me-
chanisms of various medicines have not yet been 
fully elucidated, impairment of renal function is 
observed in a number of patients receiving chemi-
cal medicines for a certain period of time. Further 
studies should be conducted to elucidate which 
are the causative factors for renal impairment in 
certain patients following use of chemical medici-
nes. Despite the advancements in pharmacology, 
there is a potential inability to justify the factors 
causing nephrotoxicity in a particular group of pa-
tients. According to homeopathic theory, the di-
sease outcome pathways and the exact causative 
factors should be considered during the progres-
sion of a disease for which suppressive therapy is 
administered. Urinary tract infections and especia-
lly recurrent febrile urinary tract infections (such 
as pyelonephritis) can lead to impairment of renal 
function. For example, recurrent urinary tract in-
fections due to the bacterium P. mirabilis cause 
permanent renal parenchyma lesions, given that 
they form infection stones [66]. Studies have also 
shown that recurrent urinary tract infections, in-
fection stones, high blood pressure, and diabetes 
mellitus appear to be high risk factors for deve-
loping chronic renal impairment. The presence of 
infections and recurrent infections in patients with 
impaired renal function can lead to CKD. Further-
more, patients with chronic renal impairment have 
an imbalanced immune system, which is a direct 
result of renal impairment as well as the primary 
disease that led to its manifestation [67]. 
Patients with recurrent infections and CKD of-
ten receive chemical medicines and /or immuno-
suppressants, such as corticosteroids and antibio-
tics, to treat their underlying conditions. In an 
effort to interpret the frequent relapses of infec-
tions from a homeopathic perspective, a potential 
miasmatic dimension of the disease arises. Accor-
ding to homeopathy, chronic predispositions are 
the reason why patients develop relapses despite 
receiving the correct treatment. Notably, in the 
phenomenon of symptom/disease "suppression," 
patients with CKD address these infection relap-
ses by taking chemical medicines, such as antibio-
tics, antipyretics, and anti-inflammatory agents. 
Hahnemann states that by treating acute infec-
tions with "allopathic" therapies and with high 
doses of medicines, local symptoms of the disea-
ses are suppressed, and the risk of chronic disease 
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is increased [15-16]. Furthermore, by aiming at 
balancing the body's vital reaction, homeopathic 
treatment seeks a holistic physiological response 
of the body. As a result, this approach is indicated 
for the treatment of both acute infections and 
chronic diseases [30, 68-71]. 
Sexually transmitted diseases are conditions of 
the urogenital system, often first manifesting them-
selves as skin conditions, such as in HPV infection, 
genital herpes, and syphilis [22-66]. They often ma-
nifest with relapses and, as a result with very few 
exceptions (e.g., genital warts), the use of antibio-
tics is needed to treat them. Once again, antibiotics 
have potential nephrotoxic properties. Approaching 
sexually transmitted diseases with the homeopathic 
concept of "disease suppression" ("when a disea-
se is not treated in depth and causally, then it is 
simply suppressed"), any disease presenting itself in 
the human body must be thoroughly cured [19]. 
By treating the symptoms, one does not treat the 
disease itself. It is simply a symptomatic treatment 
of the health disorder, not a complete cure of the 
disease. By analyzing the health course of patients 
with CKD and a history of sexually transmitted di-
seases, it is not a course leading to cure, as stated 
in Hering's Law, "from a more important organ to 
a less important one." [72] 
On the contrary, by holistically analyzing patients 
with CKD and STD, one observes that they lead 
to the manifestation of deeper pathologies. Often, 
the suppressive treatment of a disease has dama-
ging effects on the body. The suppressed disease 
tends to affect deeper structures and to settle in 
more important tissues and organs. According to 
Hahnemann, initial exposure to miasms causes lo-
cal symptoms, such as skin or venereal diseases; if 
however these symptoms are suppressed by chemi-
cal medication, the cause–the miasm–goes deeper 
and begins to manifest itself as disease of the in-
ternal organs. Therefore, one could argue that the-
re is the potential of manifestation of a miasmatic 
condition in patients with CKD and a history of 
sexually transmitted diseases [15, 16]. Furthermore, 
the deoxyribonucleic acid (DNA) of viruses, bacteria, 
and microorganisms leave an "imprint," a traceable 
frequency in the body fluids, which opens the way 
for the development of a highly sensitive detection 
system for chronic bacterial infections in human and 
animal diseases [73]. 
Our study shows that a large number of patients 
with CKD have a history of sexually transmitted di-
seases. More specifically, by focusing on gonorrhea 
with regards to the potential development of pre-
disposition/miasmatic disposition in some patients, 
it is known that the disease may present recurrent 
manifestations. Gonorrhea tends to relapse with 
no apparent development of protective immunity 
arising from previous episodes of infection. Thus, 
a new hypothesis emerges regarding gonococcal 
infections [74]. Neisseria gonorrhoeae has been as-
sociated with humans for several millennia. It has 
adapted remarkably well to the human immune 
system and, accordingly, has evolved to evade des-
truction by the host's immune defenses. Regarding 
treatment of sexually transmitted diseases, the use 
of homeopathic remedies is recommended. Each 
year, the number of CKD patients as well as those 
with sexually transmitted diseases is increased. A 
characteristic example in kidney failure is the struc-
tural and functional impairment of the nephrons, 
which are unable to maintain the body's homeos-
tasis. This could be true for patients with CKD, in 
which miasmatic conditions potentially affect the 
body's structure. Accordingly, in some CKD cases, 
the behavior of the "sick" system is predefined by 
its composition. 
Conclusions
In conclusion, the multifactorial nature of CKD and 
the complexity of the human body should be ap-
proached both through the documented research 
of conventional medicine as well as by homeo-
pathy. Further studies in patients with CKD and 
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other chronic diseases should be conducted using 
and comparing the abovementioned approaches 
and treatments. Analysis through the homeopathic 
theory of disease suppression, as well as that of 
miasms, provide a new approach, while offering 
a future prospect for conducting studies aimed at 
finding new causative factors in patients with renal 
impairment who later develop end stage CKD. New 
data and answers may therefore arise regarding 
the manifestation and course of renal impairment. 
Homeopathy provides an alternative treatment so-
lution, with lower nephrotoxicity rates and proven 
effectiveness. Taking into account the polyfarmacy 
of patients with CKD, as well as their susceptibility 
to recurrent infections due to immunosuppression, 
there is a real need for further investigation for the 
comparative study of chemical medicines used in 
conventional medicine and homeopathic prepara-
tions. 
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